EARLY SYMPTOMATIC IMPROVEMENT WITH GUSELKUMAB INDUCTION TREATMENT IN MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: RESULTS FROM THE PHASE 3 QUASAR INDUCTION STUDY

Gary R. Lichtenstein  ¹     Axel Dignass  ²     Shadi Yarandi  ³     Gary KH Huang  ³     Matthew Germinaro  ³     Ye Miao  ³     Hongyan Zhang  ³     Jaroslaw Kierkus  ⁴     Ursula Seidler  ⁵     Atsuo Maemoto  ⁶     Jessica Allegretti  ⁷     Brian Bressler  ⁸     Laurent Peyrin-Biroulet  ^9    
1 University of Pennsylvania, Philadelphia, United States
² Agaplesion Markus Hospital, Goethe University, Frankfurt, Germany
³ Janssen Research & Development, LLC, Spring House, United States
⁴ WIP Warsaw IBD Point, Warsaw, Poland
⁵ Medizinische Hochschule Klinik f. Gastroenterlogie, Hannover, Germany
⁶ Sapporo Higashi Tokushukai Hospital IBD Center, Sapporo, Japan
⁷ Brigham and Women´s Hospital, Boston, United States
⁸ University of British Columbia, Vancouver, Canada
⁹ Nancy University Hospital, Université de Lorraine, Nancy, France

Topic
IBD

Session
IL-23: Many but different? (Posters)

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)